NCT02955498View on ClinicalTrials.gov

Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Healthy Male Subjects
Interventions
DRUG

Sevikar tab. 10/40mg

Reference drug: Sevikar tab. 10/40mg, 1T, single oral administration in the fasted state

DRUG

Lodivikar tab. 5/40mg

Test drug: Lodivikar tab 5/40mg, 1T, single oral administration in the fasted state

Trial Locations (1)

430-720

Metrohospital, Anyang

All Listed Sponsors
lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT02955498 - Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivikar Tab. 5/40 mg in Healthy Adult Male Subjects | Biotech Hunter | Biotech Hunter